TY - JOUR
T1 - Vitamin B 12-Mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa
AU - Lee, Kang Mu
AU - Go, Junhyeok
AU - Yoon, Mi Young
AU - Park, Yongjin
AU - Kim, Sang Cheol
AU - Yong, Dong Eun
AU - Yoon, Sang Sun
PY - 2012/5
Y1 - 2012/5
N2 - Pseudomonas aeruginosa undergoes cell elongation and forms robust biofilms during anaerobic respiratory growth using nitrate (NO 3 -) as an alternative electron acceptor. Understanding the mechanism of cell shape change induced upon anaerobiosis is crucial to the development of effective treatments against P. aeruginosa biofilm infection. Here, we uncovered the molecular basis of anaerobiosis-triggered cell elongation and identified vitamin B 12 to be a molecule that can reinstate defective anaerobic growth of P. aeruginosa. The ratio of total cellular DNA content to protein content was significantly decreased in the PAO1 strain grown under anaerobic conditions, indicating that DNA replication is impaired during anaerobic growth. Anaerobic growth of PAO1 reached a higher cell density in the presence of vitamin B 12, an essential coenzyme of class II ribonucleotide reductase. In addition, cell morphology returned to a normal rod shape and transcription of stress-response genes was downregulated under the same anaerobic growth conditions. These results suggest that vitamin B 12, the production of which was suppressed during anaerobic growth, can restore cellular machineries for DNA replication and therefore facilitate better anaerobic growth of P. aeruginosa with normal cell division. Importantly, biofilm formation was substantially decreased when grown with vitamin B 12, further demonstrating that anaerobiosis-induced cell elongation is responsible for robust biofilm formation. Taken together, our data reveal mechanistic details of a morphological change that naturally occurs during anaerobic growth of P. aeruginosa and illustrates the ability of vitamin B 12 to modulate the biofilm-forming capacity of P. aeruginosa under such condition.
AB - Pseudomonas aeruginosa undergoes cell elongation and forms robust biofilms during anaerobic respiratory growth using nitrate (NO 3 -) as an alternative electron acceptor. Understanding the mechanism of cell shape change induced upon anaerobiosis is crucial to the development of effective treatments against P. aeruginosa biofilm infection. Here, we uncovered the molecular basis of anaerobiosis-triggered cell elongation and identified vitamin B 12 to be a molecule that can reinstate defective anaerobic growth of P. aeruginosa. The ratio of total cellular DNA content to protein content was significantly decreased in the PAO1 strain grown under anaerobic conditions, indicating that DNA replication is impaired during anaerobic growth. Anaerobic growth of PAO1 reached a higher cell density in the presence of vitamin B 12, an essential coenzyme of class II ribonucleotide reductase. In addition, cell morphology returned to a normal rod shape and transcription of stress-response genes was downregulated under the same anaerobic growth conditions. These results suggest that vitamin B 12, the production of which was suppressed during anaerobic growth, can restore cellular machineries for DNA replication and therefore facilitate better anaerobic growth of P. aeruginosa with normal cell division. Importantly, biofilm formation was substantially decreased when grown with vitamin B 12, further demonstrating that anaerobiosis-induced cell elongation is responsible for robust biofilm formation. Taken together, our data reveal mechanistic details of a morphological change that naturally occurs during anaerobic growth of P. aeruginosa and illustrates the ability of vitamin B 12 to modulate the biofilm-forming capacity of P. aeruginosa under such condition.
UR - http://www.scopus.com/inward/record.url?scp=84861114062&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861114062&partnerID=8YFLogxK
U2 - 10.1128/IAI.06161-11
DO - 10.1128/IAI.06161-11
M3 - Short survey
C2 - 22371376
AN - SCOPUS:84861114062
SN - 0019-9567
VL - 80
SP - 1639
EP - 1649
JO - Infection and Immunity
JF - Infection and Immunity
IS - 5
ER -